Liver-specific MED1 null mice do not develop liver tumors, as MED1-deficient hepatocytes do not show increased proliferation or progress to liver cancer (Jia, Viswakarma & Reddy, 2014; Matsumoto et al., 2010). This evidence concerns the gene MED1 and liver cancer.